Gastrointestinal stromal tumors, somatic mutations and candidate genetic risk variants.
Gastrointestinal stromal tumors (GISTs) are rare but treatable soft tissue sarcomas. Nearly all GISTs have somatic mutations in either the KIT or PDGFRA gene, but there are no known inherited genetic risk factors. We assessed the relationship between KIT/PDGFRA mutations and select deletions or sing...
Main Authors: | Katie M O'Brien, Irene Orlow, Cristina R Antonescu, Karla Ballman, Linda McCall, Ronald DeMatteo, Lawrence S Engel |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3630216?pdf=render |
Similar Items
-
Limits of Dideoxysequencing in the Detection of Somatic Mutations in Gastrointestinal Stromal Tumors
by: Jasek K, et al.
Published: (2015-12-01) -
SDHA loss of function mutations in a subset of young adult wild-type gastrointestinal stromal tumors
by: Italiano Antoine, et al.
Published: (2012-09-01) -
Gastrointestinal Stromal Tumor: Chondro-Myxoid Variant Mimicking Chondrosarcoma
by: Ashwani Rajput, et al.
Published: (2005-01-01) -
Personalized Medicine in Gastrointestinal Stromal Tumor (GIST): Clinical Implications of the Somatic and Germline DNA Analysis
by: Gloria Ravegnini, et al.
Published: (2015-07-01) -
Gastrointestinal stromal tumor
by: Levidou Georgia, et al.
Published: (2009-08-01)